Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
about
Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanomaGenetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways.Switching off key signaling survival molecules to switch on the resolution of inflammation.DC-81-enediyne induces apoptosis of human melanoma A375 cells: involvement of the ROS, p38 MAPK, and AP-1 signaling pathways.Phage display-derived human antibodies in clinical development and therapyEfficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma.
P2860
Q35434352-47E4E927-3B42-47D2-BF35-4E04E19D2B22Q35561369-76E6FE51-7A8F-4B2A-B77B-8034085D213FQ37492231-E8ABB4F9-03FC-46C5-81E6-921AE575F5B8Q37636774-A9D74674-E61F-4B8E-89C8-D15C5AC01CECQ37680195-FC63E7BC-F47E-44A6-AB37-F8CC2A3169DDQ38241177-5E03A642-207B-4C8C-A3DB-930923E3B745Q39215755-90B0D68C-1B7C-480F-B61C-8AE2CF243F09Q41416393-A45EFEEB-2C65-48BE-BAF2-5B2A776C96D4Q41460534-5684E637-0F2D-4CD4-84FD-9B913ED0E119
P2860
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@ast
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@en
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@nl
type
label
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@ast
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@en
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@nl
prefLabel
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@ast
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@en
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@nl
P2093
P2860
P1433
P1476
Dacarbazine and the agonistic ...... nticancer effects in melanoma.
@en
P2093
Birgit Engesæter
Olav Engebraaten
Vivi Ann Flørenes
P2860
P304
P356
10.1371/JOURNAL.PONE.0045492
P407
P577
2012-09-20T00:00:00Z